News

Data Watch: Rise Expected to Continue in World Market For Multiple Sclerosis Treatment

Publish date: August 1, 2007
PDF Download

 

ELSEVIER GLOBAL MEDICAL NEWS

Recommended Reading

Methotrexate Holds Promise for Progressive MS
MDedge Neurology
Data From Multiple Sclerosis Study Point to Locus on Chromosome 6
MDedge Neurology
Image of the Month
MDedge Neurology
Study: Natalizumab Use Poses Limited Risk of PML
MDedge Neurology
Over One-Third of MS Patients Report Missing Injections at Least Monthly
MDedge Neurology
TNF Blockade May Trigger CNS Demyelination in Some
MDedge Neurology
Demyelinating Polyneuropathy May Be Triggered by TNF Blockade Therapy
MDedge Neurology
Natalizumab's Future: Down but Not Out for MS?
MDedge Neurology
IFN-β Products Seem Equivalent as Initial Treatment for MS
MDedge Neurology